Tuesday, February 27, 2024
Platform for Therapeutics
Biograil is developing the proprietary technology BIONDD(TM) capsule delivering biologic drugs with a bioavailability like SC injection creating a broad platform for oral delivery of drugs that would otherwise need to be injected today.
CEO/Top Company Official
Lead Product in Development
Teriparatide (Biograil) Partner compound 1 (Lilly)
Development Phase of Primary Product
Number Of Unlicensed Products
Platform technology with broad potential across compounds which would need to be injected today.